Reliv' International, Inc. develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. Its nutritional supplements primarily include Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a high-fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form. The company markets and sells its products through a network of distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom. Reliv' International, Inc. was founded in 1984 and is headquartered in Chesterfield, Missouri.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:RELV
CUSIPN/A
Phone636-537-9715
Debt
Debt-to-Equity RatioN/A
Current Ratio1.25
Quick Ratio0.66
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$41.79 million
Price / Sales0.22
Cash Flow$0.3776 per share
Price / Cash13.19
Book Value$7.78 per share
Price / Book0.64
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-690,000.00
Net Margins-5.12%
Return on Equity-9.85%
Return on Assets-6.62%
Miscellaneous
Employees160
Outstanding Shares1,850,000
Market Cap$9.39 million
Reliv International (NASDAQ:RELV) Frequently Asked Questions
What is Reliv International's stock symbol?
Reliv International trades on the NASDAQ under the ticker symbol "RELV."
How were Reliv International's earnings last quarter?
Reliv International, Inc (NASDAQ:RELV) posted its quarterly earnings results on Friday, August, 10th. The company reported ($0.53) earnings per share (EPS) for the quarter. The company earned $8.46 million during the quarter. Reliv International had a negative return on equity of 9.85% and a negative net margin of 5.12%. View Reliv International's Earnings History.
When is Reliv International's next earnings date?
Who are some of Reliv International's key competitors?
Some companies that are related to Reliv International include Acerus Pharmaceuticals (TRLPF), Bellerophon Therapeutics (BLPH), Aileron Therapeutics (ALRN), ProPhase Labs (PRPH), Onconova Therapeutics (ONTX), Ceapro (CRPOF), Lipocine (LPCN), SUMMIT THERAPEU/S (SMMT), Capricor Therapeutics (CAPR), AEterna Zentaris (AEZS), Nuvo Pharmaceuticals (NRIFF), PLx Pharma (PLXP), Innovus Pharmaceuticals (INNV), NeuroVive Pharmaceutical (NEVPF) and BENITEC BIOPHAR/S (BNTC).
Who are Reliv International's key executives?
Reliv International's management team includes the folowing people:
- Mr. Robert L. Montgomery, Co-Founder & Chairman (Age 76)
- Dr. Carl W. Hastings, Vice Chairman, Chief Scientific Officer & Member of the Scientific Advisory Board (Age 76)
- Mr. Thomas W. Pinnock III, Exec. VP & Chief of Sales (Age 67)
- Mr. Ryan A. Montgomery, CEO, Pres & Director (Age 44)
- Mr. Steven D. Albright CPA, Sr. VP & CFO (Age 56)
Has Reliv International been receiving favorable news coverage?
Media stories about RELV stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group rates the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Reliv International earned a media and rumor sentiment score of 0.10 on Accern's scale. They also assigned media headlines about the company an impact score of 47.77 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days. View Recent Headlines for Reliv International.
How do I buy shares of Reliv International?
Shares of RELV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Reliv International's stock price today?
One share of RELV stock can currently be purchased for approximately $4.98.
How big of a company is Reliv International?
Reliv International has a market capitalization of $9.39 million and generates $41.79 million in revenue each year. Reliv International employs 160 workers across the globe.
How can I contact Reliv International?
Reliv International's mailing address is 136 CHESTERFIELD INDUSTRIAL BLVD, CHESTERFIELD MO, 63005. The company can be reached via phone at 636-537-9715 or via email at [email protected]
MarketBeat Community Rating for Reliv International (NASDAQ RELV)
MarketBeat's community ratings are surveys of what our community members think about Reliv International and other stocks. Vote "Outperform" if you believe RELV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RELV will underperform the S&P 500 over the long term. You may vote once every thirty days.
